GPX4 and neoplasm: For example, in a study of the treatment of triple-negative breast cancer, researchers found that tumor tissues had a different metabolic phenotype of ferroptosis from normal tissues through metabolomics, and inhibition of the key ferroptosis protein GPX4 could effectively enhance cellular anti-tumor immunity [68].